Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and immune characteristics of neuroendocrine bladder carcinoma - Implications for diagnosis, prognosis, and therapy: A review.

Biomolecules & biomedicine - 9 Oct 2025

Zhang Tianxiang, Zhang Xi, Qian Lei, Hu Chunjiang, Li Jianxing

Abstract excerpt

Neuroendocrine bladder carcinoma (NEBC) is a rare but highly aggressive histologic subtype of bladder cancer with poor prognosis, often driven by delayed diagnosis and limited therapeutic options; despite widespread use of next-generation sequencing, its cellular origin remains unclear and controversial. We aimed to synthesize up-to-date molecular and immune features of NEBC and translate them into practical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Neuroendocrine
Share to Immune Checkpoint Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Neoadjuvant Therapy

Share to Progression-Free Survival

Share to Tumor Microenvironment

Share to Urinary Bladder

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41065174
DOI: 10.17305/bb.2025.13151
PMCID: PMC12834297

Genes

GATA3
INSM1
RB1
TERT
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and immune characteristics of neuroendocrine bladder carcinoma - Implications for diagnosis, prognosis, and therapy: A review.PMID 41065174Read ↗

Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder CancerSemantic proximity Read ↗

Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.Semantic proximity Read ↗

Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder.Semantic proximity Read ↗

Distinct clonal dynamics and interactions within the microenvironment near tumor stroma interfaces in rare histologic variants of bladder cancerSemantic proximity Read ↗

Molecular Subtypes of Bladder Cancer.Semantic proximity Read ↗

International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4Semantic proximity Read ↗

Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.Semantic proximity Read ↗

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.Semantic proximity Read ↗

Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis.Semantic proximity Read ↗

Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study.Semantic proximity Read ↗

Three Conserved Immune Dysfunction and Exclusion Subtypes in Bladder and Pan-cancers: Prognostic and Immunotherapeutic SignificanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.